524238 GUJINJEC

Gujarat Inject (Kerala) Share Price

 

 

Start SIP in GUJINJEC

Start SIP

Performance

  • Low
  • ₹55
  • High
  • ₹56
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹56
  • Open Price₹55
  • Previous Close₹55
  • Volume51,228
  • 50 DMA₹40.92
  • 100 DMA₹34.71
  • 200 DMA₹29.35

Investment Returns

  • Over 1 Month + 40.67%
  • Over 3 Month + 118.56%
  • Over 6 Month + 164.29%
  • Over 1 Year + 97.86%

Smart Investing Starts Here Start SIP with Gujarat Inject (Kerala) for Steady Growth!

Invest Now

Gujarat Inject (Kerala) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 191.2
  • PEG Ratio
  • -4.2
  • Market Cap Cr
  • 81
  • P/B Ratio
  • 8
  • Average True Range
  • 1.43
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.24
  • RSI
  • 96.02
  • MFI
  • 92.89

Gujarat Inject (Kerala) Financials

Gujarat Inject (Kerala) Technicals

EMA & SMA

Current Price
₹55.58
+ 1.08 (1.98%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹48.19
  • 50 Day
  • ₹40.92
  • 100 Day
  • ₹34.71
  • 200 Day
  • ₹29.35

Resistance and Support

55.39 Pivot Speed
  • R3 56.35
  • R2 55.97
  • R1 55.77
  • S1 55.19
  • S2 54.81
  • S3 54.61

Gujarat Inject (Kerala) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-20 Audited Results
2025-02-18 Stock Split
2025-01-23 Quarterly Results

Gujarat Inject (Kerala) F&O

Gujarat Inject (Kerala) Shareholding Pattern

0%
90.02%
9.98%

Gujarat Inject (Kerala) FAQs

Gujarat Inject (Kerala) share price is ₹55 As on 12 February, 2026 | 05:30

The Market Cap of Gujarat Inject (Kerala) is ₹81.4 Cr As on 12 February, 2026 | 05:30

The P/E ratio of Gujarat Inject (Kerala) is 191.2 As on 12 February, 2026 | 05:30

The PB ratio of Gujarat Inject (Kerala) is 8 As on 12 February, 2026 | 05:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23